首页 > 最新文献

Tumour Virus Research最新文献

英文 中文
A peptide derived from sorting nexin 1 inhibits HPV16 entry, retrograde trafficking, and L2 membrane spanning 一种从分拣奈克辛 1 提取的多肽可抑制 HPV16 的进入、逆行运输和 L2 膜跨越。
IF 4.7 Q1 VIROLOGY Pub Date : 2024-06-21 DOI: 10.1016/j.tvr.2024.200287
Shuaizhi Li , Zachary L. Williamson , Matthew A. Christofferson , Advait Jeevanandam , Samuel K. Campos

High risk human papillomavirus (HPV) infection is responsible for 99 % of cervical cancers and 5 % of all human cancers worldwide. HPV infection requires the viral genome (vDNA) to gain access to nuclei of basal keratinocytes of epithelium. After virion endocytosis, the minor capsid protein L2 dictates the subcellular retrograde trafficking and nuclear localization of the vDNA during mitosis. Prior work identified a cell-permeable peptide termed SNX1.3, derived from the BAR domain of sorting nexin 1 (SNX1), that potently blocks the retrograde and nuclear trafficking of EGFR in triple negative breast cancer cells. Given the importance of EGFR and retrograde trafficking pathways in HPV16 infection, we set forth to study the effects of SNX1.3 within this context. SNX1.3 inhibited HPV16 infection by both delaying virion endocytosis, as well as potently blocking virion retrograde trafficking and Golgi localization. SNX1.3 had no effect on cell proliferation, nor did it affect post-Golgi trafficking of HPV16. Looking more directly at L2 function, SNX1.3 was found to impair membrane spanning of the minor capsid protein. Future work will focus on mechanistic studies of SNX1.3 inhibition, and the role of EGFR signaling and SNX1-mediated endosomal tubulation, cargo sorting, and retrograde trafficking in HPV infection.

全球 99% 的宫颈癌和 5% 的人类癌症都是由高危人类乳头瘤病毒(HPV)感染引起的。HPV 感染需要病毒基因组(vDNA)进入上皮基底角质细胞核。病毒内吞后,次要帽状蛋白 L2 决定了 vDNA 在有丝分裂过程中的亚细胞逆行运输和核定位。之前的研究发现了一种细胞渗透性多肽 SNX1.3,该多肽来自分选神经蛋白 1(SNX1)的 BAR 结构域,能有效阻断表皮生长因子受体在三阴性乳腺癌细胞中的逆行和核运输。鉴于表皮生长因子受体和逆行运输途径在 HPV16 感染中的重要性,我们开始研究 SNX1.3 在此背景下的作用。SNX1.3 既能延缓病毒的内吞,又能有效阻断病毒的逆行贩运和高尔基体定位,从而抑制 HPV16 感染。SNX1.3 对细胞增殖没有影响,也不影响 HPV16 在高尔基体后的贩运。从更直接的 L2 功能来看,SNX1.3 会影响小帽膜蛋白的膜跨越。未来的工作将侧重于 SNX1.3 抑制的机理研究,以及表皮生长因子受体信号转导和 SNX1 介导的内体管化、货物分拣和逆向贩运在 HPV 感染中的作用。
{"title":"A peptide derived from sorting nexin 1 inhibits HPV16 entry, retrograde trafficking, and L2 membrane spanning","authors":"Shuaizhi Li ,&nbsp;Zachary L. Williamson ,&nbsp;Matthew A. Christofferson ,&nbsp;Advait Jeevanandam ,&nbsp;Samuel K. Campos","doi":"10.1016/j.tvr.2024.200287","DOIUrl":"10.1016/j.tvr.2024.200287","url":null,"abstract":"<div><p>High risk human papillomavirus (HPV) infection is responsible for 99 % of cervical cancers and 5 % of all human cancers worldwide. HPV infection requires the viral genome (vDNA) to gain access to nuclei of basal keratinocytes of epithelium. After virion endocytosis, the minor capsid protein L2 dictates the subcellular retrograde trafficking and nuclear localization of the vDNA during mitosis. Prior work identified a cell-permeable peptide termed SNX1.3, derived from the BAR domain of sorting nexin 1 (SNX1), that potently blocks the retrograde and nuclear trafficking of EGFR in triple negative breast cancer cells. Given the importance of EGFR and retrograde trafficking pathways in HPV16 infection, we set forth to study the effects of SNX1.3 within this context. SNX1.3 inhibited HPV16 infection by both delaying virion endocytosis, as well as potently blocking virion retrograde trafficking and Golgi localization. SNX1.3 had no effect on cell proliferation, nor did it affect post-Golgi trafficking of HPV16. Looking more directly at L2 function, SNX1.3 was found to impair membrane spanning of the minor capsid protein. Future work will focus on mechanistic studies of SNX1.3 inhibition, and the role of EGFR signaling and SNX1-mediated endosomal tubulation, cargo sorting, and retrograde trafficking in HPV infection.</p></div>","PeriodicalId":52381,"journal":{"name":"Tumour Virus Research","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2024-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666679024000119/pdfft?md5=1250a168dc79de16a0d68ff0fe70f4a3&pid=1-s2.0-S2666679024000119-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial board member 编辑委员会成员
IF 4.3 Q1 Medicine Pub Date : 2024-06-01 DOI: 10.1016/S2666-6790(24)00007-7
{"title":"Editorial board member","authors":"","doi":"10.1016/S2666-6790(24)00007-7","DOIUrl":"https://doi.org/10.1016/S2666-6790(24)00007-7","url":null,"abstract":"","PeriodicalId":52381,"journal":{"name":"Tumour Virus Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666679024000077/pdfft?md5=c4a2481106c457dd4f74fcb7a3d9596e&pid=1-s2.0-S2666679024000077-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141315018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cervical cytology and HPV distribution in Cape Verde: A snapshot of a country taken during its first HPV nation-wide vaccination campaign 佛得角的宫颈细胞学和人类乳头瘤病毒分布情况:首次在全国范围内开展人类乳头瘤病毒疫苗接种活动期间的国家快照。
IF 4.3 Q1 Medicine Pub Date : 2024-06-01 DOI: 10.1016/j.tvr.2024.200280
Rita Vieira , Diana Montezuma , Carla Barbosa , Isabel Macedo Pinto

Cervical cancer ranks as the third most common female cancer in Cape Verde and is the leading cause of cancer-related deaths among women in the country. While Human Papillomavirus (HPV) vaccination, which started in 2021, is anticipated to significantly reduce disease incidence, cervical screening remains crucial for non-vaccinated women. We retrospectively reviewed gynecologic cytology exams and HPV tests performed in Cape Verde between 2017 and April 2023 and processed at IMP Diagnostics. For this study, we considered 13035 women with cytology examinations performed and, 2013 of these, also with an HPV molecular test. Cytology diagnostics comprised 83 % NILM cases; 12 % ASC-US; 2.7 % LSIL; 1.2 % ASC-H; 0.5 % HSIL and 0.1 % SCC. In 505 (25.1 %) high-risk HPV infection was detected. Prevalence of HPV infection varied with age, peaking at young ages - ≤24 years old (55.5 %) and 25-35-year-old women (31.5 %) - and the lowest after 66 years old (9.7 %). Herein we present a comprehensive study regarding Cape Verde's cervical cytology and HPV distribution, aiming to provide a snapshot of the country's cervical cytology results and HPV distribution in recent years. Moreover, these data may contribute to establish a baseline to assess, in the future, the vaccination impact in the country.

宫颈癌是佛得角第三大最常见的女性癌症,也是该国妇女因癌症死亡的主要原因。虽然 2021 年开始的人乳头状瘤病毒(HPV)疫苗接种预计将大大降低疾病的发病率,但宫颈筛查对于未接种疫苗的妇女仍然至关重要。我们回顾性地审查了 2017 年至 2023 年 4 月期间在佛得角进行的妇科细胞学检查和 HPV 检测,并在 IMP 诊断公司进行了处理。在这项研究中,我们考虑了 13035 名进行过细胞学检查的女性,其中 2013 名还进行了 HPV 分子检测。细胞学诊断包括83%的NILM病例;12%的ASC-US;2.7%的LSIL;1.2%的ASC-H;0.5%的HSIL和0.1%的SCC。在 505 例(25.1%)中检测到高危 HPV 感染。HPV感染率随年龄而变化,年轻女性感染率最高,≤24岁(55.5%),25-35岁(31.5%),66岁以后感染率最低(9.7%)。在此,我们提交了一份有关佛得角宫颈细胞学和人乳头瘤病毒分布情况的综合研究报告,旨在提供该国近年来宫颈细胞学结果和人乳头瘤病毒分布情况的快照。此外,这些数据还有助于建立一个基线,以便将来评估疫苗接种在该国的影响。
{"title":"Cervical cytology and HPV distribution in Cape Verde: A snapshot of a country taken during its first HPV nation-wide vaccination campaign","authors":"Rita Vieira ,&nbsp;Diana Montezuma ,&nbsp;Carla Barbosa ,&nbsp;Isabel Macedo Pinto","doi":"10.1016/j.tvr.2024.200280","DOIUrl":"10.1016/j.tvr.2024.200280","url":null,"abstract":"<div><p>Cervical cancer ranks as the third most common female cancer in Cape Verde and is the leading cause of cancer-related deaths among women in the country. While Human Papillomavirus (HPV) vaccination, which started in 2021, is anticipated to significantly reduce disease incidence, cervical screening remains crucial for non-vaccinated women. We retrospectively reviewed gynecologic cytology exams and HPV tests performed in Cape Verde between 2017 and April 2023 and processed at IMP Diagnostics. For this study, we considered 13035 women with cytology examinations performed and, 2013 of these, also with an HPV molecular test. Cytology diagnostics comprised 83 % NILM cases; 12 % ASC-US; 2.7 % LSIL; 1.2 % ASC-H; 0.5 % HSIL and 0.1 % SCC. In 505 (25.1 %) high-risk HPV infection was detected. Prevalence of HPV infection varied with age, peaking at young ages - ≤24 years old (55.5 %) and 25-35-year-old women (31.5 %) - and the lowest after 66 years old (9.7 %). Herein we present a comprehensive study regarding Cape Verde's cervical cytology and HPV distribution, aiming to provide a snapshot of the country's cervical cytology results and HPV distribution in recent years. Moreover, these data may contribute to establish a baseline to assess, in the future, the vaccination impact in the country.</p></div>","PeriodicalId":52381,"journal":{"name":"Tumour Virus Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666679024000041/pdfft?md5=64eb631123fa06b8823a59b3dee4cc51&pid=1-s2.0-S2666679024000041-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140871204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Juvenile onset recurrent respiratory papillomatosis: What do we know in 2024 ? 青少年复发性呼吸道乳头状瘤病:2024 年我们将知道什么?
IF 4.3 Q1 Medicine Pub Date : 2024-04-27 DOI: 10.1016/j.tvr.2024.200281
Charles Lepine , Nicolas Leboulanger , Cécile Badoual

Juvenile onset recurrent respiratory papillomatosis is a lifelong benign squamous lesion associated with HPV infection, particularly HPV6 and HPV11 genotypes. These lesions are rare, but can lead to laryngeal obturations, which can cause disabling dyspnea, or transform into squamous cell carcinoma. The aim here is to provide an epidemiological, biological and clinical overview of this pathology, particularly in children, in order to understand the issues at stake in terms of research and the development of medical and therapeutic management tools.

幼年复发性呼吸道乳头状瘤病是一种终身性良性鳞状病变,与人乳头状瘤病毒感染有关,尤其是人乳头状瘤病毒 6 和人乳头状瘤病毒 11 基因型。这种病变很少见,但可导致喉闭塞,引起致残性呼吸困难,或转化为鳞状细胞癌。本文旨在从流行病学、生物学和临床角度概述这种病变,尤其是儿童病变,以便了解在研究和开发医疗及治疗管理工具方面存在的问题。
{"title":"Juvenile onset recurrent respiratory papillomatosis: What do we know in 2024 ?","authors":"Charles Lepine ,&nbsp;Nicolas Leboulanger ,&nbsp;Cécile Badoual","doi":"10.1016/j.tvr.2024.200281","DOIUrl":"https://doi.org/10.1016/j.tvr.2024.200281","url":null,"abstract":"<div><p>Juvenile onset recurrent respiratory papillomatosis is a lifelong benign squamous lesion associated with HPV infection, particularly HPV6 and HPV11 genotypes. These lesions are rare, but can lead to laryngeal obturations, which can cause disabling dyspnea, or transform into squamous cell carcinoma. The aim here is to provide an epidemiological, biological and clinical overview of this pathology, particularly in children, in order to understand the issues at stake in terms of research and the development of medical and therapeutic management tools.</p></div>","PeriodicalId":52381,"journal":{"name":"Tumour Virus Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666679024000053/pdfft?md5=b93f2e4869c9a623105e0c8d405d110b&pid=1-s2.0-S2666679024000053-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140823868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HPV16 E7 modulates the cell surface expression of MET and CD109 via the AP2 complex HPV16 E7 通过 AP2 复合物调节细胞表面 MET 和 CD109 的表达。
IF 4.3 Q1 Medicine Pub Date : 2024-03-12 DOI: 10.1016/j.tvr.2024.200279
Oscar Trejo-Cerro , Om Basukala , Michael P. Myers , Lawrence Banks

Multiple cellular pathways are affected by HPV E6 and E7 oncoproteins, including endocytic and cellular trafficking. HPV-16 E7 can target the adaptor protein (AP) complex, which contains proteins important during endocytosis transport. To further investigate the role of HPV E7 during this process, we analysed the expression of cell surface proteins in NIKS cells expressing HPV-16 E7. We show that different cell surface proteins are regulated by HPV-16 E7 via interaction with AP2. We observed that the expression of MET and CD109 membrane protein seems to be upregulated in cells expressing E7. Moreover, the interaction of MET and CD109 with AP2 proteins is disrupted by HPV-16 E7. In addition, in the absence of HPV-16 E7, there is a downregulation of the cell membrane expression of MET and CD109 in HPV-positive cell lines. These results expand our knowledge of the functions of E7 and open new potential cellular pathways affected by this oncoprotein.

多种细胞通路会受到 HPV E6 和 E7 肿瘤蛋白的影响,包括内吞和细胞转运。HPV-16 E7 可靶向适配蛋白(AP)复合物,该复合物包含内吞转运过程中的重要蛋白质。为了进一步研究 HPV E7 在这一过程中的作用,我们分析了表达 HPV-16 E7 的 NIKS 细胞中细胞表面蛋白的表达情况。我们发现,HPV-16 E7 通过与 AP2 相互作用调控不同的细胞表面蛋白。我们观察到,在表达 E7 的细胞中,MET 和 CD109 膜蛋白的表达似乎被上调。此外,HPV-16 E7 破坏了 MET 和 CD109 与 AP2 蛋白的相互作用。此外,在没有 HPV-16 E7 的情况下,HPV 阳性细胞系中 MET 和 CD109 的细胞膜表达下调。这些结果拓展了我们对 E7 功能的认识,并开辟了受这种肿瘤蛋白影响的新的潜在细胞通路。
{"title":"HPV16 E7 modulates the cell surface expression of MET and CD109 via the AP2 complex","authors":"Oscar Trejo-Cerro ,&nbsp;Om Basukala ,&nbsp;Michael P. Myers ,&nbsp;Lawrence Banks","doi":"10.1016/j.tvr.2024.200279","DOIUrl":"10.1016/j.tvr.2024.200279","url":null,"abstract":"<div><p>Multiple cellular pathways are affected by HPV E6 and E7 oncoproteins, including endocytic and cellular trafficking. HPV-16 E7 can target the adaptor protein (AP) complex, which contains proteins important during endocytosis transport. To further investigate the role of HPV E7 during this process, we analysed the expression of cell surface proteins in NIKS cells expressing HPV-16 E7. We show that different cell surface proteins are regulated by HPV-16 E7 via interaction with AP2. We observed that the expression of MET and CD109 membrane protein seems to be upregulated in cells expressing E7. Moreover, the interaction of MET and CD109 with AP2 proteins is disrupted by HPV-16 E7. In addition, in the absence of HPV-16 E7, there is a downregulation of the cell membrane expression of MET and CD109 in HPV-positive cell lines. These results expand our knowledge of the functions of E7 and open new potential cellular pathways affected by this oncoprotein.</p></div>","PeriodicalId":52381,"journal":{"name":"Tumour Virus Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266667902400003X/pdfft?md5=7080733ec5725ed90815ab591a98a958&pid=1-s2.0-S266667902400003X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140133170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surveillance of human papillomavirus through salivary diagnostics - A roadmap to early detection of oropharyngeal cancer men 通过唾液诊断监测人类乳头瘤病毒--男性口咽癌早期检测路线图。
IF 4.3 Q1 Medicine Pub Date : 2024-03-03 DOI: 10.1016/j.tvr.2024.200278
Akila Wijesekera , Chameera Ekanayake Weeramange , Sarju Vasani , Liz Kenny , Emma Knowland , Jayampath Seneviratne , Chamindie Punyadeera

Human papillomavirus (HPV) is the most common sexually transmitted disease. Certain strains have the potential to cause malignancy in multiple anatomical sites if not cleared by the immune system. In most infected people, HPV is cleared within two years. However, HPV may persist in susceptible individuals with certain risk factors, eventually leading to malignancy. New evidence suggests that over 75% of all oropharyngeal cancers (OPC) are directly attributable to HPV. It is estimated that prophylactic HPV vaccination alone may take at least 25 years to have a significant impact on reducing the incidence of OPC. The temporal link between detection of oral HPV, persistence of the infection and the subsequent development of OPC have been well established. Moreover, men have threefold higher risk than women for acquiring HPV-OPC. This comprehensive review focuses on OPC development in men, highlighting the risk factors associated with malignant transformation of HPV-OPC. Current evidence is insufficient to determine whether early identification of at-risk demographics, screening, and prompt diagnosis result in improved outcomes. Hitherto, the effectiveness of an oral HPV screening program in this regard has not been investigated. Nevertheless, the potential to emulate the success of the cervical screening program remains a very real possibility.

人类乳头瘤病毒(HPV)是最常见的性传播疾病。某些病毒株如果不被免疫系统清除,有可能在多个解剖部位引发恶性肿瘤。大多数感染者的 HPV 会在两年内被清除。然而,HPV 可能会在具有某些风险因素的易感人群中持续存在,最终导致恶性肿瘤。新证据表明,超过 75% 的口咽癌(OPC)可直接归因于 HPV。据估计,单靠预防性 HPV 疫苗接种可能至少需要 25 年才能对降低口咽癌发病率产生显著影响。口腔人乳头瘤病毒的检测、感染的持续存在以及随后发展成 OPC 之间的时间联系已得到充分证实。此外,男性感染 HPV-OPC 的风险是女性的三倍。本综述重点关注男性 OPC 的发展,强调与 HPV-OPC 恶性转化相关的风险因素。目前的证据不足以确定早期识别高危人群、筛查和及时诊断是否能改善预后。迄今为止,口腔 HPV 筛查项目在这方面的有效性尚未得到研究。尽管如此,仿效宫颈筛查计划的成功仍有很大的可能性。
{"title":"Surveillance of human papillomavirus through salivary diagnostics - A roadmap to early detection of oropharyngeal cancer men","authors":"Akila Wijesekera ,&nbsp;Chameera Ekanayake Weeramange ,&nbsp;Sarju Vasani ,&nbsp;Liz Kenny ,&nbsp;Emma Knowland ,&nbsp;Jayampath Seneviratne ,&nbsp;Chamindie Punyadeera","doi":"10.1016/j.tvr.2024.200278","DOIUrl":"10.1016/j.tvr.2024.200278","url":null,"abstract":"<div><p>Human papillomavirus (HPV) is the most common sexually transmitted disease. Certain strains have the potential to cause malignancy in multiple anatomical sites if not cleared by the immune system. In most infected people, HPV is cleared within two years. However, HPV may persist in susceptible individuals with certain risk factors, eventually leading to malignancy. New evidence suggests that over 75% of all oropharyngeal cancers (OPC) are directly attributable to HPV. It is estimated that prophylactic HPV vaccination alone may take at least 25 years to have a significant impact on reducing the incidence of OPC. The temporal link between detection of oral HPV, persistence of the infection and the subsequent development of OPC have been well established. Moreover, men have threefold higher risk than women for acquiring HPV-OPC. This comprehensive review focuses on OPC development in men, highlighting the risk factors associated with malignant transformation of HPV-OPC. Current evidence is insufficient to determine whether early identification of at-risk demographics, screening, and prompt diagnosis result in improved outcomes. Hitherto, the effectiveness of an oral HPV screening program in this regard has not been investigated. Nevertheless, the potential to emulate the success of the cervical screening program remains a very real possibility.</p></div>","PeriodicalId":52381,"journal":{"name":"Tumour Virus Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666679024000028/pdfft?md5=5d8c4900240ff112522756ab200f6d35&pid=1-s2.0-S2666679024000028-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140040875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
E4orf1: The triple agent of adenovirus – Unraveling its roles in oncogenesis, infectious obesity and immune responses in virus replication and vector therapy E4orf1:腺病毒的三重药剂--揭示其在肿瘤发生、传染性肥胖以及病毒复制和载体治疗中的免疫反应中的作用。
IF 4.3 Q1 Medicine Pub Date : 2024-02-28 DOI: 10.1016/j.tvr.2024.200277
Lilian Göttig , Sabrina Schreiner

Human Adenoviruses (HAdV) are nearly ubiquitous pathogens comprising numerous sub-types that infect various tissues and organs. Among many encoded proteins that facilitate viral replication and subversion of host cellular processes, the viral E4orf1 protein has emerged as an intriguing yet under-investigated player in the complex interplay between the virus and its host. E4orf1 has gained attention as a metabolism activator and oncogenic agent, while recent research is showing that E4orf1 may play a more important role in modulating cellular pathways such as PI3K-Akt-mTOR, Ras, the immune response and further HAdV replication stages than previously anticipated.

In this review, we aim to explore the structure, molecular mechanisms, and biological functions of E4orf1, shedding light on its potentially multifaceted roles during HAdV infection, including metabolic diseases and oncogenesis. Furthermore, we discuss the role of functional E4orf1 in biotechnological applications such as Adenovirus (AdV) vaccine vectors and oncolytic AdV. By dissecting the intricate relationships between HAdV types and E4orf1 proteins, this review provides valuable insights into viral pathogenesis and points to promising areas of future research.

人类腺病毒(HAdV)是一种几乎无处不在的病原体,由许多亚型组成,可感染各种组织和器官。在许多促进病毒复制和颠覆宿主细胞过程的编码蛋白中,病毒 E4orf1 蛋白已成为病毒与其宿主之间复杂相互作用中一个令人感兴趣但研究不足的角色。E4orf1 作为一种新陈代谢激活剂和致癌物质而备受关注,而最近的研究表明,E4orf1 在调节 PI3K-Akt-mTOR、Ras、免疫反应和 HAdV 进一步复制阶段等细胞通路方面可能发挥着比以前预期的更重要的作用。在这篇综述中,我们旨在探讨 E4orf1 的结构、分子机制和生物功能,揭示其在 HAdV 感染过程中可能发挥的多方面作用,包括代谢性疾病和肿瘤发生。此外,我们还讨论了功能性 E4orf1 在腺病毒(AdV)疫苗载体和溶瘤 AdV 等生物技术应用中的作用。通过剖析 HAdV 类型和 E4orf1 蛋白之间错综复杂的关系,这篇综述为病毒的发病机制提供了宝贵的见解,并指出了未来有希望的研究领域。
{"title":"E4orf1: The triple agent of adenovirus – Unraveling its roles in oncogenesis, infectious obesity and immune responses in virus replication and vector therapy","authors":"Lilian Göttig ,&nbsp;Sabrina Schreiner","doi":"10.1016/j.tvr.2024.200277","DOIUrl":"10.1016/j.tvr.2024.200277","url":null,"abstract":"<div><p>Human Adenoviruses (HAdV) are nearly ubiquitous pathogens comprising numerous sub-types that infect various tissues and organs. Among many encoded proteins that facilitate viral replication and subversion of host cellular processes, the viral E4orf1 protein has emerged as an intriguing yet under-investigated player in the complex interplay between the virus and its host. E4orf1 has gained attention as a metabolism activator and oncogenic agent, while recent research is showing that E4orf1 may play a more important role in modulating cellular pathways such as PI3K-Akt-mTOR, Ras, the immune response and further HAdV replication stages than previously anticipated.</p><p>In this review, we aim to explore the structure, molecular mechanisms, and biological functions of E4orf1, shedding light on its potentially multifaceted roles during HAdV infection, including metabolic diseases and oncogenesis. Furthermore, we discuss the role of functional E4orf1 in biotechnological applications such as Adenovirus (AdV) vaccine vectors and oncolytic AdV. By dissecting the intricate relationships between HAdV types and E4orf1 proteins, this review provides valuable insights into viral pathogenesis and points to promising areas of future research.</p></div>","PeriodicalId":52381,"journal":{"name":"Tumour Virus Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666679024000016/pdfft?md5=c1289e68488a5387087db9e3293fa36e&pid=1-s2.0-S2666679024000016-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140013742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analytical validation and diagnostic performance of the ASCL1/ZNF582 methylation test for detection of high-grade anal intraepithelial neoplasia and anal cancer 用于检测高级别肛门上皮内瘤变和肛门癌的 ASCL1/ZNF582 甲基化检验的分析验证和诊断性能。
IF 4.3 Q1 Medicine Pub Date : 2023-12-30 DOI: 10.1016/j.tvr.2023.200275
Kirsten Rozemeijer , Fernando Dias Gonçalves Lima , Timo J. ter Braak , Albertus T. Hesselink , Jan M. Prins , Henry J.C. de Vries , Renske D.M. Steenbergen

DNA methylation testing on biopsies can detect high-grade anal intraepithelial neoplasia (HGAIN) in need of treatment and anal cancer. This study aimed to analytically validate and determine the diagnostic performance of a newly developed multiplex quantitative methylation-specific PCR, PreCursor-M AnoGYN (RUO), combining ASCL1, ZNF582 and a reference (ACTB) in one assay. Analytical validation was performed on two qPCR devices using predefined quality criteria. Diagnostic performance was determined on a cross-sectional series of 111 anal biopsies covering all stages of anal disease. Differences in methylation levels were assessed using the Kruskal-Wallis test. Area under the curve was determined using logistic regression analysis. Detection rates were calculated at predefined specificities for the cross-sectional and an additional longitudinal series of 23 HGAIN biopsies preceding anal cancer (i.e., progressive HGAIN).

For both devices analytical quality criteria were met. ASCL1 and ZNF582 methylation levels increased with increasing severity of disease (p < 6*10−8). Diagnostic performance for AIN3+ was 0.81. All cancers and virtually all progressive HGAIN were detected at 70% and 80% specificity.

In conclusion, the ASCL1/ZNF582 methylation test (PreCursor-M AnoGYN (RUO)) was demonstrated to be highly robust and reproducible. Moreover, it had excellent diagnostic accuracy to detect AIN3+ and can potentially be used to guide HGAIN management.

对活检组织进行 DNA 甲基化检测可以发现需要治疗的高级别肛门上皮内瘤变(HGAIN)和肛门癌。本研究旨在分析验证和确定新开发的多重甲基化特异性定量 PCR PreCursor-M AnoGYN(RUO)的诊断性能。使用预定义的质量标准在两台 qPCR 设备上进行了分析验证。对 111 例肛门活检的横断面系列进行了诊断性能测定,涵盖了肛门疾病的所有阶段。甲基化水平的差异采用 Kruskal-Wallis 检验进行评估。采用逻辑回归分析确定曲线下面积。按照预定的特异性计算了肛门癌(即进展期 HGAIN)之前的横断面和另外 23 个纵向 HGAIN 活检系列的检出率。两种设备均符合分析质量标准。ASCL1 和 ZNF582 甲基化水平随病情严重程度的增加而增加(p -8)。AIN3+ 的诊断率为 0.81。所有癌症和几乎所有进行性 HGAIN 的检测特异性分别为 70% 和 80%。总之,ASCL1/ZNF582 甲基化检测(PreCursor-M AnoGYN(RUO))被证明具有高度的稳健性和可重复性。此外,它在检测 AIN3+ 方面具有极高的诊断准确性,可用于指导 HGAIN 管理。
{"title":"Analytical validation and diagnostic performance of the ASCL1/ZNF582 methylation test for detection of high-grade anal intraepithelial neoplasia and anal cancer","authors":"Kirsten Rozemeijer ,&nbsp;Fernando Dias Gonçalves Lima ,&nbsp;Timo J. ter Braak ,&nbsp;Albertus T. Hesselink ,&nbsp;Jan M. Prins ,&nbsp;Henry J.C. de Vries ,&nbsp;Renske D.M. Steenbergen","doi":"10.1016/j.tvr.2023.200275","DOIUrl":"10.1016/j.tvr.2023.200275","url":null,"abstract":"<div><p>DNA methylation testing on biopsies can detect high-grade anal intraepithelial neoplasia (HGAIN) in need of treatment and anal cancer. This study aimed to analytically validate and determine the diagnostic performance of a newly developed multiplex quantitative methylation-specific PCR, PreCursor-M AnoGYN (RUO), combining <em>ASCL1, ZNF582</em> and a reference (<em>ACTB</em>) in one assay. Analytical validation was performed on two qPCR devices using predefined quality criteria. Diagnostic performance was determined on a cross-sectional series of 111 anal biopsies covering all stages of anal disease. Differences in methylation levels were assessed using the Kruskal-Wallis test. Area under the curve was determined using logistic regression analysis. Detection rates were calculated at predefined specificities for the cross-sectional and an additional longitudinal series of 23 HGAIN biopsies preceding anal cancer (i.e., progressive HGAIN).</p><p>For both devices analytical quality criteria were met. <em>ASCL1</em> and <em>ZNF582</em> methylation levels increased with increasing severity of disease (<em>p &lt; 6*10</em><sup><em>−8</em></sup>). Diagnostic performance for AIN3<sup>+</sup> was 0.81. All cancers and virtually all progressive HGAIN were detected at 70% and 80% specificity.</p><p>In conclusion, the <em>ASCL1/ZNF582</em> methylation test (PreCursor-M AnoGYN (RUO)) was demonstrated to be highly robust and reproducible. Moreover, it had excellent diagnostic accuracy to detect AIN3<sup>+</sup> and can potentially be used to guide HGAIN management.</p></div>","PeriodicalId":52381,"journal":{"name":"Tumour Virus Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2023-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666679023000228/pdfft?md5=c19dacaf0f34ae20fdc44257cf56f0c3&pid=1-s2.0-S2666679023000228-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139075780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epstein-Barr Virus miR-BARTs 7 and 9 modulate viral cycle, cell proliferation, and proteomic profiles in Burkitt lymphoma Epstein-Barr 病毒 miR-BARTs 7 和 9 调节伯基特淋巴瘤的病毒周期、细胞增殖和蛋白质组特征。
IF 4.3 Q1 Medicine Pub Date : 2023-12-29 DOI: 10.1016/j.tvr.2023.200276
Brunno Felipe Ramos Caetano , Viviana Loureiro Rocha , Bruno Cesar Rossini , Lucilene Delazari Dos Santos , Deilson Elgui De Oliveira

The Epstein-Barr Virus (EBV) encodes viral microRNAs (miRs) that have been implicated in the pathogenesis of nasopharyngeal and gastric carcinomas, yet their potential roles in lymphomas remain to be fully elucidated. This study evaluated the impact of CRISPR/Cas9-mediated knockdown of EBV miRs BART-7 and BART-9 in EBV-positive Burkitt lymphoma cells Akata. As anticipated, the Akata cells subjected to CRISPR/Cas9-mediated knockdown of either EBV BART-7 or BART-9 exhibited a significant reduction in the expression of these viral miRs compared to cells with wild-type (wt) EBV genomes. This outcome effectively validates the experimental model employed in this study. Knocking down either BART-7 or BART-9 resulted in a notable reduction in cell viability and proliferation rates, alongside an elevation in the expression of EBV lytic genes. Global proteomic analysis revealed that the knockdown of EBV BART-7 significantly decreased the expression of ubiquitin/proteasome proteins while concurrently increasing RNA binding proteins (RBPs). Conversely, BART-9 knockdown reduced proteins associated with oxidoreductase activity, particularly those involved in fatty acid metabolism. Our findings unveil previously undiscovered EBV miRs BARTs 7 and 9 roles in cellular pathways relevant to both viral biology and lymphomagenesis.

爱泼斯坦-巴氏病毒(EBV)编码的病毒微RNA(miRs)有助于鼻咽癌和胃癌的发病机制,但它们在淋巴瘤中的潜在作用仍有待阐明。本研究试图利用 CRISPR/Cas9 技术评估敲除 EBV miRs BART 7 和 BART9 对 EBV 阳性 Akata 细胞系的影响。与携带野生型(WT)EBV基因组的细胞相比,经CRISPR/Cas9介导敲除EBV BART 7和BART9的Akata细胞显示病毒miRs的表达明显减少,证实了实验模型的有效性。敲除 BART7 和 BART9 会显著降低细胞活力和增殖率,同时增加 EBV 溶菌基因的表达。全局蛋白质组分析表明,敲除 EBV BART7 会显著降低泛素/蛋白酶体蛋白的表达,同时增加 RNA 结合蛋白(RBPs)。另一方面,敲除 BART9 会导致与氧化还原酶活性(包括脂肪酸代谢)相关的蛋白质减少。我们的研究结果揭示了 EBV miRs BART7 和 BART9 在与病毒生物学和淋巴瘤发生相关的细胞通路中的未知作用。
{"title":"Epstein-Barr Virus miR-BARTs 7 and 9 modulate viral cycle, cell proliferation, and proteomic profiles in Burkitt lymphoma","authors":"Brunno Felipe Ramos Caetano ,&nbsp;Viviana Loureiro Rocha ,&nbsp;Bruno Cesar Rossini ,&nbsp;Lucilene Delazari Dos Santos ,&nbsp;Deilson Elgui De Oliveira","doi":"10.1016/j.tvr.2023.200276","DOIUrl":"10.1016/j.tvr.2023.200276","url":null,"abstract":"<div><p>The Epstein-Barr Virus (EBV) encodes viral microRNAs (miRs) that have been implicated in the pathogenesis of nasopharyngeal and gastric carcinomas, yet their potential roles in lymphomas remain to be fully elucidated. This study evaluated the impact of CRISPR/Cas9-mediated knockdown of EBV miRs BART-7 and BART-9 in EBV-positive Burkitt lymphoma cells Akata. As anticipated, the Akata cells subjected to CRISPR/Cas9-mediated knockdown of either EBV BART-7 or BART-9 exhibited a significant reduction in the expression of these viral miRs compared to cells with wild-type (wt) EBV genomes. This outcome effectively validates the experimental model employed in this study. Knocking down either BART-7 or BART-9 resulted in a notable reduction in cell viability and proliferation rates, alongside an elevation in the expression of EBV lytic genes. Global proteomic analysis revealed that the knockdown of EBV BART-7 significantly decreased the expression of ubiquitin/proteasome proteins while concurrently increasing RNA binding proteins (RBPs). Conversely, BART-9 knockdown reduced proteins associated with oxidoreductase activity, particularly those involved in fatty acid metabolism. Our findings unveil previously undiscovered EBV miRs BARTs 7 and 9 roles in cellular pathways relevant to both viral biology and lymphomagenesis.</p></div>","PeriodicalId":52381,"journal":{"name":"Tumour Virus Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266667902300023X/pdfft?md5=316875d8e9bcf16995d37e8248320697&pid=1-s2.0-S266667902300023X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139075781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial board member 编辑委员会成员
IF 4.3 Q1 Medicine Pub Date : 2023-12-01 DOI: 10.1016/S2666-6790(23)00020-4
{"title":"Editorial board member","authors":"","doi":"10.1016/S2666-6790(23)00020-4","DOIUrl":"https://doi.org/10.1016/S2666-6790(23)00020-4","url":null,"abstract":"","PeriodicalId":52381,"journal":{"name":"Tumour Virus Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666679023000204/pdfft?md5=fcc7ece21927473f77be1905dd91d6b5&pid=1-s2.0-S2666679023000204-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138838605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Tumour Virus Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1